American Assets Investment Management’s Novartis NVS Stock Holding History

American Assets Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.3M	Hold	93,610	–	–	0.97%	28
2025 Q4	$12.9M	Hold	93,610	–	–	0.89%	31
2025 Q3	$12M	Hold	93,610	–	–	0.88%	32
2025 Q2	$11.3M	Hold	93,610	–	–	0.91%	28
2025 Q1	$10.4M	Hold	93,610	–	–	0.91%	31
2024 Q4	$9.11M	Hold	93,610	–	–	0.74%	37
2024 Q3	$10.8M	Hold	93,610	–	–	0.94%	28
2024 Q2	$9.97M	Hold	93,610	–	–	0.93%	28
2024 Q1	$9.05M	Hold	93,610	–	–	0.86%	36
2023 Q4	$9.45M	Hold	93,610	–	–	0.98%	24
2023 Q3	$9.54M	Hold	93,610	–	–	1.06%	20
2023 Q2	$9.45M	Hold	93,610	–	–	1.05%	21
2023 Q1	$8.61M	Hold	93,610	–	–	0.99%	27
2022 Q4	$8.49M	Hold	93,610	–	–	0.98%	31
2022 Q3	$7.12M	Hold	93,610	–	–	0.93%	32
2022 Q2	$7.91M	Hold	93,610	–	–	0.99%	27
2022 Q1	$8.21M	Hold	93,610	–	–	0.87%	29
2021 Q4	$8.19M	Hold	93,610	–	–	0.88%	30
2021 Q3	$7.66M	Hold	93,610	–	–	0.95%	28
2021 Q2	$8.54M	Hold	93,610	–	–	1.12%	21
2021 Q1	$8M	Hold	93,610	–	–	1.1%	25
2020 Q4	$8.84M	Hold	93,610	–	–	1.44%	14
2020 Q3	$8.14M	Hold	93,610	–	–	1.68%	11
2020 Q2	$8.18M	Sell	93,610 -15,000	-14%	-$1.29M	1.85%	11
2020 Q1	$8.96M	Hold	108,610	–	–	1.92%	6
2019 Q4	$10.3M	Hold	108,610	–	–	1.54%	10
2019 Q3	$9.44M	Hold	108,610	–	–	1.51%	11
2019 Q2	$9.92M	Sell	108,610 -12,599	-10%	-$1.07M	1.58%	10
2019 Q1	$10.4M	Hold	121,209	–	–	1.69%	7
2018 Q4	$9.32M	Hold	121,209	–	–	1.68%	7
2018 Q3	$9.35M	Hold	121,209	–	–	1.54%	10
2018 Q2	$8M	Hold	121,209	–	–	1.4%	12
2018 Q1	$8.78M	Hold	121,209	–	–	1.67%	10
2017 Q4	$9.12M	Buy	121,209 +11,897	+11%	+$898K	1.75%	9
2017 Q3	$8.41M	Hold	109,312	–	–	1.68%	9
2017 Q2	$8.18M	Hold	109,312	–	–	1.69%	9
2017 Q1	$7.28M	Buy	109,312 +4,587	+4%	+$306K	1.48%	11
2016 Q4	$6.83M	Buy	104,725 +46,961	+81%	+$3.05M	1.45%	14
2016 Q3	$4.09M	Hold	57,764	–	–	0.94%	29
2016 Q2	$4.27M	Hold	57,764	–	–	1.04%	25
2016 Q1	$3.75M	Hold	57,764	–	–	1.02%	26
2015 Q4	$4.45M	Hold	57,764	–	–	1.23%	18
2015 Q3	$4.76M	Hold	57,764	–	–	1.44%	16
2015 Q2	$5.09M	Hold	57,764	–	–	1.52%	13
2015 Q1	$5.1M	Hold	57,764	–	–	1.63%	12
2014 Q4	$4.8M	Hold	57,764	–	–	1.51%	16
2014 Q3	$4.87M	Hold	57,764	–	–	1.73%	12
2014 Q2	$4.69M	Hold	57,764	–	–	1.32%	16
2014 Q1	$4.4M	Hold	57,764	–	–	1.38%	15
2013 Q4	$4.16M	Hold	57,764	–	–	1.56%	12
2013 Q3	$3.97M	Sell	57,764 -2,455	-4%	-$162K	1.4%	13
2013 Q2	$3.82M	Buy	+60,219	New	+$3.92M	1.41%	10

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Assets Investment Management's NVS Position: Q1 2026 in Review

American Assets Investment Management held its Novartis (NVS) position steady in Q1 2026 at 93,610 shares worth $14.3M. The position accounts for 0.97% of the portfolio, ranked #28.

American Assets Investment Management first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

American Assets Investment Management held 93,610 shares of Novartis worth $14.3M as of Q1 2026.
American Assets Investment Management left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.97% of American Assets Investment Management's portfolio in Q1 2026, its #28 holding.
American Assets Investment Management first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on American Assets Investment Management's 13F filing for Q1 2026, filed 11 May 2026.